You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-HEF1 antibody [2G9] (ab18056)

CodeSizePriceAbpointsAvailability
    
 
  • -

  •   
  •   
  •   
  •  

  •  
  •  
  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Overview

Product name

Anti-HEF1 antibody [2G9]
See all HEF1 products (6) ...

Description

Mouse monoclonal [2G9] to HEF1

Specificity

Does not recognize p130 Cas. Not tested on Sin1. This antibody mostly detects HEF1 localized at the focal adhesion sites.

Tested applications

WB, IP, IF, ICC/IF, IHC-Fr, Flow Cytmore details

Cross reactivity

Reacts with

Mouse, Rat, Human

Immunogen

Fusion protein, corresponding to amino acids 82-398 of Human HEF1.

Positive control

MCF7, Hela, SKMEL5 (human), NIH 3T3, MEF (mouse), 3Y1 (rat) and CHO (hamster) cell lines.

Properties

Form

Liquid

Storage instructions

Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

Storage buffer

Preservative: 0.1% Sodium Azide
Constituents: PBS, pH 7.2

Concentration

Concentration information loading...

Purity

Protein G purified

Clonality

Monoclonal

Clone number

2G9

Myeloma

Sp2/0

Isotype

IgG1

Light chain type

kappa

  • Immunocytochemistry/ Immunofluorescence - HEF1 antibody [2G9] (ab18056)Immunocytochemistry/ Immunofluorescence - HEF1 antibody [2G9] (ab18056) image (enlarge)

  • Western blot - HEF1 antibody [2G9] (ab18056)Western blot - HEF1 antibody [2G9] (ab18056) image (enlarge)

  • Flow Cytometry - HEF1 antibody [2G9] (ab18056)Flow Cytometry - HEF1 antibody [2G9] (ab18056) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab18056 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Target

Function

Docking protein which plays a central coordinating role for tyrosine-kinase-based signaling related to cell adhesion. May function in transmitting growth control signals between focal adhesions at the cell periphery and the mitotic spindle in response to adhesion or growth factor signals initiating cell proliferation. May play an important role in integrin beta-1 or B cell antigen receptor (BCR) mediated signaling in B- and T-cells. Integrin beta-1 stimulation leads to recruitment of various proteins including CRK, NCK and SHPTP2 to the tyrosine phosphorylated form.

Tissue specificity

Widely expressed. Higher levels detected in kidney, lung, and placenta. Also detected in T-cells, B-cells and diverse cell lines. The protein has been detected in lymphocytes, in diverse cell lines, and in lung tissues.

Sequence similarities

Belongs to the CAS family.
Contains 1 SH3 domain.

Domain

Contains a central domain containing multiple potential SH2-binding sites and a C-terminal domain containing a divergent helix-loop-helix (HLH) motif. The SH2-binding sites putatively bind CRK, NCK and ABL SH2 domains. The HLH motif confers specific interaction with the HLH proteins ID2, E12 and E47. It is absolutely required for the induction of pseudohyphal growth in yeast and mediates homodimerization and heterodimerization with p130cas.
The SH3 domain interacts with two proline-rich regions of focal adhesion kinase.

Post-translational
modifications

Cell cycle-regulated processing produces four isoforms: p115, p105, p65, and p55. Isoform p115 arises from p105 phosphorylation and appears later in the cell cycle. Isoform p55 arises from p105 as a result of cleavage at a caspase cleavage-related site and it appears specifically at mitosis. The p65 isoform is poorly detected.
Focal adhesion kinase 1 phosphorylates the protein at the YDYVHL motif (conserved among all cas proteins). The SRC family kinases (FYN, SRC, LCK and CRK) are recruited to the phosphorylated sites and can phosphorylate other tyrosine residues. Ligation of either integrin beta-1 or B-cell antigen receptor on tonsillar B-cells and B-cell lines promotes tyrosine phosphorylation and both integrin and BCR-mediated tyrosine phosphorylation requires an intact actin network. In fibroblasts transformation with oncogene v-ABL results in an increase in tyrosine phosphorylation. Transiently phosphorylated following CD3 cross-linking and this phosphorylated form binds to CRK and C3G. A mutant lacking the SH3 domain is phosphorylated upon CD3 cross-linking but not upon integrin beta-1 cross-linking. Tyrosine phosphorylation occurs upon stimulation of the G-protein coupled C1a calcitonin receptor in rabbit. Calcitonin-stimulated tyrosine phosphorylation is mediated by calcium- and protein kinase C-dependent mechanisms and requires the integrity of the actin cytoskeleton.

Cellular localization

Cytoplasm > cytoskeleton > spindle and Cytoplasm > cell cortex. Nucleus. Golgi apparatus. Cell projection > lamellipodium. Cytoplasm. Cell junction > focal adhesion. Localizes to both the cell nucleus and the cell periphery and is differently localized in fibroblasts and epithelial cells. In fibroblasts is predominantly nuclear and in some cells is present in the Golgi apparatus. In epithelial cells localized predominantly in the cell periphery with particular concentration in lamellipodia but is also found in the nucleus. Isoforms p105 and p115 are predominantly cytoplasmic and associate with focal adhesions while p55 associates with mitotic spindle.

Target information above from: UniProt accessionQ14511 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • CAS L antibody
  • Cas like docking antibody
  • Cas scaffolding protein family member 2 antibody
  • CAS-L antibody
  • CAS2 antibody
  • CASL antibody
  • CASL_HUMAN antibody
  • CASS2 antibody
  • Crk associated substrate related protein antibody
  • CRK-associated substrate-related protein antibody
  • dJ49G10.2 (Enhancer of Filamentation 1 (HEF1)) antibody
  • dJ49G10.2 antibody
  • dJ761I2.1 (enhancer of filamentation (HEF1)) antibody
  • dJ761I2.1 antibody
  • Enhancer of filamentation 1 antibody
  • Enhancer of filamentation 1 p55 antibody
  • HEF 1 antibody
  • HEF1 antibody
  • NEDD 9 antibody
  • NEDD-9 antibody
  • NEDD9 antibody
  • NEDD9 protein antibody
  • Neural cell expressed developmentally down regulated 9 antibody
  • Neural precursor cell expressed developmentally down regulated 9 antibody
  • Neural precursor cell expressed developmentally down-regulated protein 9 antibody
  • NY REN 12 antigen antibody
  • p105 antibody
  • Protein NEDD9 antibody
  • Renal carcinoma antigen NY-REN-12 antibody
see all

Anti-HEF1 antibody [2G9] images:

  Immunocytochemistry/ Immunofluorescence - HEF1 antibody [2G9] (ab18056)

Immunocytochemistry/ Immunofluorescence - HEF1 antibody [2G9] (ab18056)

ICC/IF image of ab18056 stained Mcf7 cells. The cells were 4% formaldehyde fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab18056, 1µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-mouse IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.

  Western blot - HEF1 antibody [2G9] (ab18056)

Western blot - HEF1 antibody [2G9] (ab18056)

Anti-HEF1 antibody [2G9] (ab18056) at 1/2000 dilution + whole cell lysate prepared from a murine neural stem cell line at 15 µg

Secondary
HRP conjugated anti mouse IgG (H+L) at 1/3000 dilution
developed using the ECL technique

Predicted band size : 93 kDa
Observed band size : 105 kDa (why is the actual band size different from the predicted?)
Additional bands at : 115 kDa. We are unsure as to the identity of these extra bands.

Exposure time : 1 hour

Image courtesy of an Abreview submitted by Melina Reisenberg.

  Flow Cytometry - HEF1 antibody [2G9] (ab18056)

Flow Cytometry - HEF1 antibody [2G9] (ab18056)

Overlay histogram showing A549 cells stained with ab18056 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab18056, 1µg/1x106 cells) for 30 min at 22ºC. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22ºC. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 2µg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in A549 cells fixed with 4% paraformaldehyde (10 min)/permeabilized in 0.1% PBS-Tween used under the same conditions.

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HEF1 antibody [2G9] (ab18056)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HEF1 antibody [2G9] (ab18056)

IHC image of ab18056 staining in human kidney formalin fixed paraffin embedded tissue section, performed on a Leica BondTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab18056, 10µg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.

For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.

References for Anti-HEF1 antibody [2G9] (ab18056)

This product has been referenced in:

  • Kong C  et al. NEDD9 Is a Positive Regulator of Epithelial-Mesenchymal Transition and Promotes Invasion in Aggressive Breast Cancer. PLoS One 6:e22666 (2011). WB; Human.Read more (PubMed: 21829474) »
  • Vogel T  et al. Transforming growth factor beta promotes neuronal cell fate of mouse cortical and hippocampal progenitors in vitro and in vivo: identification of Nedd9 as an essential signaling component. Cereb Cortex 20:661-71 (2010). ICC/IF; Mouse.Read more (PubMed: 19587023) »

See all 7 publications for this product

Publishing research using ab18056? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"